Sort
326,823 grants matching “clinical trial”
Discovery and Analytical Validation of Inflammatory Bio-Signatures of the Human Pain Experience
$2,381,168Alan Rodney Prossin · University Of Texas Hlth Sci Ctr Houston · R61 · FY2019 · NS
COG SDMC - Administrative Core
$2,381,128Todd A Alonzo · Public Health Institute · U10 · FY2022 · CA
Program Project â Improving Provider Announcement Communication Training (IMPACT)
$2,381,047Noel Todd Brewer · Univ Of North Carolina Chapel Hill · P01 · FY2021 · CA
The Duke Senescent Cell Evaluations in Normal Tissues (SCENT) Mapping Center
$2,381,000Andrew B Nixon · Duke University · U54 · FY2022 · AG
2/2-A Comparison of Long-Acting Injectable Medications for Schizophrenia -ACLAIMS
$2,380,698Thomas Scott Stroup · Columbia University Health Sciences · R01 · FY2012 · MH
Co-occurring ADHD in young children with ASD: Precursors, detection, neural signatures, and early treatment
$2,380,519Geraldine Dawson · Duke University · P50 · FY2017 · HD
COMPREHENSIVE SICKLE CELL CENTER
$2,380,476Children'S Hospital Of Philadelphia · P60 · FY2000 · HL
Developing a NAMPT activator for Alzheimerâs disease
$2,380,457Beibei Chen · University Of Pittsburgh At Pittsburgh · U01 · FY2023 · AG
Investigation On The Behavior And Related Neuro-Electrochemistry Of Potential Medications For The Treatment Of Substance Use Disorders.
$2,380,406Gianluigi Tanda · National Institute On Drug Abuse · ZIA · FY2022 · DA
Project-002
$2,380,344Jose Szapocznik · University Of Miami School Of Medicine · UG1 · FY2016 · DA
Development of PPL-138, a Novel Mixed NOP/Mu Partial Agonist for Treatment of CocaineUse Disorder
$2,380,269Lawrence R Toll · Phoenix Pharmalabs, Inc. · U01 · FY2023 · DA
Type 2 Diabetes Mellitus and Vascular Contributions to Cognitive Impairment and Dementia (T2DM-VCID)
$2,380,018Deborah Allison Levine · University Of Michigan At Ann Arbor · RF1 · FY2024 · NS
SPORE in Prostate Cancer
$2,380,000Arul M Chinnaiyan · University Of Michigan At Ann Arbor · P50 · FY2017 · CA
SPORE in Pancreatic Cancer
$2,379,383Michael A Hollingsworth · University Of Nebraska Medical Center · P50 · FY2017 · CA
Dental PBRN Network Chair
$2,379,163Gregg H Gilbert · University Of Alabama At Birmingham · U01 · FY2010 · DE
Influenza Vaccine Development
$2,378,449Barney Graham · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI
CTSA INFRASTRUCTURE FOR AIDS RESEARCH
$2,378,277S. Claiborne Johnston · University Of California, San Francisco · UL1 · FY2011 · RR
CTSA INFRASTRUCTURE FOR AIDS RESEARCH
$2,378,277S. Claiborne Johnston · University Of California, San Francisco · UL1 · FY2011 · RR
Clinical Evaluation of C4X3256, a Non-Opioid, Highly-Selective Orexin-1 Receptor Antagonist for the Treatment of Opioid Use Disorder
$2,378,184Christian Arthur Heidbreder · Indivior, Inc. · UH3 · FY2023 · DA
New Approaches to Inducing Cardiac Allograft Tolerance
$2,377,801Joren C Madsen · Massachusetts General Hospital · P01 · FY2024 · HL
Childhood Obesity Treatment: A Maintenance Approach
$2,377,618Denise Ella Wilfley · Washington University · R01 · FY2009 · HD
A vaccine design to induce protective B and T cell immunity against hepatitis C virus
$2,377,023Steven Foung · Stanford University · U19 · FY2021 · AI
Developing a NAMPT activator for Alzheimerâs disease
$2,376,637Beibei Chen · University Of Pittsburgh At Pittsburgh · U01 · FY2024 · AG
THE IMPACTA PERU CLINICAL TRIALS UNIT
$2,376,608Jorge Luis Sanchez · Asociacion Civil Impacta Salud Y Educacn · UM1 · FY2012 · AI
CANCER CENTER SUPPORT GRANT
$2,376,242Gerold Bepler · Wayne State University · P30 · FY2013 · CA